GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
F

Feedback FDBK.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

3.85p

-1.28%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Feedback

Its shares trade on LSE under the ticker FDBK.L. It has been listed since 8 January 1986. In the fiscal year to 31 May 2025, it reported revenue of £885,623 and a net loss of £7.3m. At that date it held total assets of £6.8m and shareholders' equity of £6.2m.

Feedback Plc operates as an investing company, which seeks to acquire a direct interest in one or more companies in the technology sector. The company is headquartered in Cambridge, Cambridgeshire. The firm is engaged in providing imaging tools for clinical decision makers. The firm is engaged in developing techniques and managing workflow for medical practitioners involved in research and in treating patients. The firm offers TexRAD, which is engaged in providing medical research and it can be used to manage clinical trials and helps to manage pharmaceuticals. The firm is engaged in identifying imaging biomarkers that can be used in detection of cancer. The company offers Cadran, a medical imaging tools for decision support. Cadran Image Storage Management offers fully featured image display, review and manipulation options and enterprise archiving for clinical, non-clinical and teaching use. The firm's subsidiaries include Feedback Black Box Company Limited, Feedback Data GmbH, Brickshield Limited, Cambridge Computed Imaging Limited, TexRAD Limited and Prostate Checker Ltd.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Technology
Listed since
8 Jan 1986
Employees
25
Website
fbk.com ↗

Leadership

Pay as last reported

  • Prof. Rory ShawIndependent Non-Executive Chairman of the Board£40,000
  • Dr. Thomas OakleyChief Executive Officer, Executive Director, since 2019£228,389
  • Mr. Aneshkumar PatelChief Financial Officer, Executive Director, since 2021£216,183
  • Mr. Stephen McateerChief Operating Officer
  • Mr. Michael HayballChief Technology Officer, since 2015£83,250
  • Dr. Stephen BrownChief Information Officer
  • Mr. Nick MayhewChief Marketing and Sales Officer
  • Mr. Mark FletcherDirector of External Affairs
  • Mr. Adam DenningNon-Executive Independent Director£25,000
  • Ms. Annemijn EschauzierNon-Executive Independent Director£25,000
  • Mr. Philipp PrinceNon-Executive Independent Director£25,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Feedback PLC has 25 employees focused on Health Care technology sector.
  • TexRAD provides medical research and clinical trial management tools.
  • Cadran offers medical imaging decision support with image storage management.

Weaknesses

  • Feedback PLC has only 25 employees in the Health Care sector.
  • The company's subsidiaries include Feedback Black Box Company Limited and others.
  • Feedback PLC's business is limited to imaging tools for clinical decision makers.

Opportunities

  • Feedback PLC can expand TexRAD for pharmaceutical management.
  • Feedback PLC can leverage Cadran for enterprise archiving solutions.
  • Feedback PLC's subsidiaries include TexRAD Limited for medical research.

Threats

  • Feedback PLC faces competition in the Health Care imaging tools market.
  • The company's small size with 25 employees may limit growth.
  • Feedback PLC's focus on imaging biomarkers for cancer detection is narrow.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.